Atrás
Rango del Día
$26.84
$28.45
Rango de 52 Semanas
$4.81
$44.89
Volumen
368,182
Promedio 50D / 200D
$35.10
/
$22.42
Cierre Anterior
$28.14
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -10.8 | 0.3 |
| P/B | 2.5 | 2.9 |
| ROE % | -27.8 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$55.33
+98.9%
Low: $18.00
High: $88.00
EPS Futuro
-$2.85
Ingresos Est.
0
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$1.61
-$1.61 – -$1.61
|
260 M | 5 |
| FY2029 |
-$3.09
-$3.09 – -$3.09
|
130 M | 2 |
| FY2028 |
-$4.44
-$5.85 – -$1.87
|
27 M | 7 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -81.88M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-27.76%
ROIC-19.89%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio24.62
Interest Coverage0.00
Valoración
P/E Ratio
-10.75
P/B Ratio2.53
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -86.97M |
| ROE | -27.76% | ROA | -22.58% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -81.88M |
| ROIC | -19.89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 24.62 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.75 | P/B Ratio | 2.53 |
| P/S Ratio | N/A | PEG Ratio | -0.46 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 934.56M | Enterprise Value | 859.87M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -86.97M | -61.92M | -32.56M | -26.14M |
| EPS (Diluted) | -2.38 | -1.85 | -1.02 | -0.82 |
| Gross Profit | -248,000.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -98.06M | -68.19M | -35.31M | -25.16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 385.14M | 268.54M | 84.18M | 45.10M |
| Total Liabilities | 15.92M | 11.09M | 156.65M | 87.70M |
| Shareholders' Equity | 369.22M | 257.44M | -72.47M | -42.61M |
| Total Debt | 596,000.0 | 171,000.0 | 324,000.0 | 461,000.0 |
| Cash & Equivalents | 75.29M | 49.35M | 30.52M | 24.21M |
| Current Assets | 381.54M | 267.29M | 83.47M | 44.21M |
| Current Liabilities | 15.50M | 11.05M | 3.93M | 3.43M |